body{display:block;}

Library: Webinars On-Demand

In our library you can discover the webinars that took place since 2019. The webinars were broadcasted in English and Russian. Choose your language and experience what experts from all over the world discussed for the hot topics in various therapeutic areas.

Webinars On-Demand: Respiratory

  • Respiratory Recording of the Live Webinar on 04th Nov 2021
    ICS IN ASTHMA: POWER OF DIFFERENCES<br>(EXPERT OPINION)
    Please login or register to watch our Webinars on demand.

    ICS IN ASTHMA: POWER OF DIFFERENCES
    (EXPERT OPINION)

    • Are all inhaled corticosteroids the same or can we have more benefits from one of them?
      Prof. Dave Singh (UK)

      Dave Singh is Professor of Clinical Pharmacology & Respiratory Medicine at the University of Manchester.

      After graduating in medicine at Cambridge University, he specialized in clinical pharmacology and respiratory medicine.

      The development of new drugs for asthma and COPD is his primary interest of research.

      • Member of the Global initiative for the management of chronic Obstructive Lung Disease (GOLD) Science Committee
      • Chair of the European Respiratory Society airway pharmacology group
      • An Editor of the British Journal of Clinical Pharmacology, of the European Respiratory Journal.

    • Discussion
  • Respiratory Recording of the Live Webinar on 26th Oct 2021
    Asthma: What doctors need to know?
    Please login or register to watch our Webinars on demand.

    Asthma: What doctors need to know?

    • Do we understand astma and severe asthma?
      Prof. Roland Buhl (Germany)
      Head Pulmonary Department, Mainz
      University Hospital
    • Making sense of the different treatment options for severe asthma patients.
      Prof. Ian Pavord
      Professor of Respiratory Medicine at the University of Oxford and Honorary Consultant Physician at the Oxford University Hospitals
    • Severe Asthma management in the COVID-19 era
      Prof. Santiago Quirce
      Head of Allergology Department, La Paz University Hospital
    • Q&A Session
  • Respiratory Recording of the Live Webinar on 14th Oct 2021
    COPD and Eosinophilic ASTHMA: knowledge‘s essence we can use in practice. After ERS-2021 discussion.
    Please login or register to watch our Webinars on demand.

    COPD and Eosinophilic ASTHMA: knowledge‘s essence we can use in practice. After ERS-2021 discussion.

    • Real world evidence: Mepolizumab for Severe Eosinophilic Asthma
      Prof. Peter Howarth (United Kingdom)
      Global Clinical Scientific Lead at GSK, Professor emeritus in Allergy and Respiratory Medicine at the University of Southampton
    • Update on evidence for single inhaler triple therapy in COPD
      Prof. Dr. Neil Barnes (United Kingdom)
      Global Clinical Science Lead at GSK
    • Q&A interactive session
  • Respiratory Recording of the Live Webinar on 24th Jun 2021
    Allergies in children and adults. How to identify a viral infection during allergy season?
    Please login or register to watch our Webinars on demand.

    Allergies in children and adults. How to identify a viral infection during allergy season?

    • Allergies and Urticaria – the role of second generation antihistamines in the treatment
      Prof. Ralph Mösges (Germany)
      University professor, FAAAAI (MD, PhD, MSEE), Cologne, Germany
    • From atopic march to Bronchial Asthma – the potential role of antihistamine in prevention
      Prof. Ulrich Wahn (Germany)
      University professor, Charité, Berlin, Germany
    • Managing respiratory viral infection in children during allergy season
      Prof. Ninel Revenco (Moldova)
      University professor, Chief of Pediatric Department, State University of Medicine and Pharmacy „N.Testemitanu”, Chisinau, Moldova.
    • 3:40-4:00 pm
      Q&A interactive session
  • Respiratory Recording of the Live Webinar on 27th May 2021
    Respiratory webinar 2021 on Real World Evidence on asthma
    Please login or register to watch our Webinars on demand.

    Respiratory webinar 2021 on Real World Evidence on asthma

    • An introduction to RWE in asthma
      Prof. Roland Buhl (Germany)
      Head Pulmonary Department, Mainz University Hospital
    • Optimising asthma control in daily practice: RWE and therapeutic index of ICS
      Prof. Dave Singh (UK)
      Professor of clinical pharmacology & respiratory medicine at the Uni­versity of Manchester; Medical director of the Medicines Evaluation Unit; Member of the GOLD Science Committee
    • Severe asthma biologic treatment, data from RWE
      Prof. Giorgio Walter Canonica (Italy)
      Professor of Respiratory Medicine at Humanitas University, Milan-Italy & Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital IRCCS-Milano Italy
    • Q&A Session
  • Respiratory Recording of the Live Webinar on 06th Apr 2021
    Closed Triple (TRELEGY Ellipta) – the benefits we need to know and the differences we should consider
    Please login or register to watch our Webinars on demand.

    Closed Triple (TRELEGY Ellipta) – the benefits we need to know and the differences we should consider

    • Prof. Dr. Neil Barnes (United Kingdom)
      Medical Head of the Global respiratory Franchise at GSK
      Closed Triple (TRELEGY Ellipta) – the benefits we need to know and the differences we should consider
    • Q&A interactive session
  • Respiratory Recording of the Live Webinar on 03rd Dec 2020
    COPD: Hot topics concerning SARS-CoV-2 pandemic
    Please login or register to watch our Webinars on demand.

    COPD: Hot topics concerning SARS-CoV-2 pandemic

    • Prof. Dr. Johann Christian Virchow (Germany)
      MD, FRCP, FCCP, FAAAAI, Professor of Medicine and Pneumology, Head of the Departments of Pulmonary Medicine and Intensive Care Medicine in the University Medical Clinic at the University of Rostock, Germany; Medical Director of the Pulmonary Diagnostic Services and the Sleep Laboratory of the University of Rostock, Germany
      COPD-exacerbations‘ prevention: more than just to remember, but time to act
    • Prof. Dave Singh (United Kingdom)
      Professor of clinical pharmacology & respiratory medicine at the University of Manchester; Medical director of the Medicines Evaluation Unit; Member of the GOLD Science Committee; Chair of the European Respiratory Society airway pharmacology group; Editor of the European Respiratory Journal and European Respiratory Review; Fellow of the European Respiratory Society and of the British Pharmacology Society
      ICS: risks and benefits for COPD patients during the COVID-19 pandemic
    • Q&A interactive session